Neuropace shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $106k | 10k | 10.31 |
| 2025-03-31 | $538k | 44k | 12.29 |
| 2024-12-31 | $725k | 65k | 11.19 |
| 2024-09-30 | $84k | 12k | 6.97 |
| 2024-06-30 | $44k | 5.8k | 7.56 |
| 2024-03-31 | $424k | 32k | 13.20 |
| 2023-12-31 | $117k | 11k | 10.31 |
| 2022-03-31 | $27k | 3.3k | 8.11 |
| 2021-12-31 | $50k | 5.0k | 10.10 |